NCT04139746 is a NA clinical trial of Scleral Buckling in Retina Detachment, sponsored by Università degli Studi di Brescia.

Who is sponsoring NCT04139746?

NCT04139746 is sponsored by Università degli Studi di Brescia.

What drugs are being tested in NCT04139746?

Interventions in NCT04139746: Scleral Buckling, Drainage-Injection-Pneumoretinopexy.

What condition does NCT04139746 study?

NCT04139746 studies Retina Detachment.

Is NCT04139746 still recruiting?

NCT04139746 is currently completed. Last updated 25 October 2019.

Last reviewed 2019-10-25 · How we verify

NCT04139746

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pneumatic Retinopexy for Severe Bullous Retinal Detachment

Completed NA Last updated 25 October 2019

What this trial tests

NA trial testing Scleral Buckling in Retina Detachment in 58 participants. Completed in 30 June 2019.

Timeline

1 March 2017

Primary endpoint
1 March 2019

30 June 2019

Quick facts

Lead sponsor	Università degli Studi di Brescia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	58
Start date	1 March 2017
Primary completion	1 March 2019
Estimated completion	30 June 2019
Sites	1 location across Italy

Drugs / interventions tested

Scleral Buckling
Drainage-Injection-Pneumoretinopexy

Conditions studied

Retina Detachment — all drugs for Retina Detachment →

Sponsor

Università degli Studi di Brescia — full company profile →

Who can join

Under 60, any sex, with Retina Detachment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the efficacy and safety outcomes of scleral buckling (SB) and drainage-injection-pneumoretinopexy (DIP), a modified pneumatic retinopexy technique, in which, before injecting the gas, the drainage of the subretinal fluid is performed with a simultaneous injection of balanced salt solution (BSS) in the vitreous chamber, for the treatment of severe superior bullous rhegmatogenous retinal detachment (SBRD).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Pneumatic retinopexy versus scleral buckle for repairing simple rhegmatogenous retinal detachments.
Sena DF, Kilian R, Liu SH, Rizzo S, et al · · 2021 · cited 5× · PMID 34762741 · DOI 10.1002/14651858.cd008350.pub3

Verify or expand the search:

Other Università degli Studi di Brescia trials

Trials by the same sponsor.

NCT07316413 — Repetitive Transcranial Magnetic Stimulation in Frontotemporal Lobar Degeneration · NA · recruiting
NCT07275398 — Experimental Study on Exercise and Well-being in University Students · NA · completed
NCT05705037 — MIH and Hypersensitivity in Children · NA · unknown
NCT05045105 — Timing of Invasive Intracranial Pressure Monitoring Between Neurosurgeons and Intensive Care Physicians · unknown
NCT04441866 — Automated Analysis Algorithms in Second Trimester Obstetric Ultrasound · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04139746 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Università degli Studi di Brescia
Last refreshed: 25 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04139746.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing